Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;126(2):243-249.
doi: 10.1007/s11547-020-01291-y. Epub 2020 Oct 12.

Quantitative Chest CT analysis in discriminating COVID-19 from non-COVID-19 patients

Affiliations

Quantitative Chest CT analysis in discriminating COVID-19 from non-COVID-19 patients

Damiano Caruso et al. Radiol Med. 2021 Feb.

Abstract

Introduction: COVID-19 pneumonia is characterized by ground-glass opacities (GGOs) and consolidations on Chest CT, although these CT features cannot be considered specific, at least on a qualitative analysis. The aim is to evaluate if Quantitative Chest CT could provide reliable information in discriminating COVID-19 from non-COVID-19 patients.

Materials and methods: From March 31, 2020 until April 18, 2020, patients with Chest CT suggestive for interstitial pneumonia were retrospectively enrolled and divided into two groups based on positive/negative COVID-19 RT-PCR results. Patients with pulmonary resection and/or CT motion artifacts were excluded. Quantitative Chest CT analysis was performed with a dedicated software that provides total lung volume, healthy parenchyma, GGOs, consolidations and fibrotic alterations, expressed both in liters and percentage. Two radiologists in consensus revised software analysis and adjusted areas of lung impairment in case of non-adequate segmentation. Data obtained were compared between COVID-19 and non-COVID-19 patients and p < 0.05 were considered statistically significant. Performance of statistically significant parameters was tested by ROC curve analysis.

Results: Final population enrolled included 190 patients: 136 COVID-19 patients (87 male, 49 female, mean age 66 ± 16) and 54 non-COVID-19 patients (25 male, 29 female, mean age 63 ± 15). Lung quantification in liters showed significant differences between COVID-19 and non-COVID-19 patients for GGOs (0.55 ± 0.26L vs 0.43 ± 0.23L, p = 0.0005) and fibrotic alterations (0.05 ± 0.03 L vs 0.04 ± 0.03 L, p < 0.0001). ROC analysis of GGOs and fibrotic alterations showed an area under the curve of 0.661 (cutoff 0.39 L, 68% sensitivity and 59% specificity, p < 0.001) and 0.698 (cutoff 0.02 L, 86% sensitivity and 44% specificity, p < 0.001), respectively.

Conclusions: Quantification of GGOs and fibrotic alterations on Chest CT could be able to identify patients with COVID-19.

Keywords: COVID-19; Chest CT; Interstitial pneumonia; Quantitative Chest CT analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Flowchart of the study. From the initial population of 216 Chest CT positive for interstitial pneumonia, we enrolled 136 patients COVID-19 and 54 patients non-COVID-19
Fig. 2
Fig. 2
57-year-old man with COVID-19 (a, b) and 58-year-old man non-COVID-19 (c, d). Axial unenhanced quantified Chest CT scans that show diffuse bilateral ground-glass opacities (GGOs) and some fibrotic alterations in COVID-19 patient (a, b) and rare ground-glass opacities in non-COVID-19 patient (c, d). Chest CT semi-automatic quantification shows GGOs in red, vessels in yellow and fibrotic alterations in blue, these findings are more represented in COVID-19 patient (a) then in non-COVID-19 patient (c)
Fig. 3
Fig. 3
ROC curves to test the ability of ground-glass opacities and fibrotic alterations in differentiating COVID-19 from non-COVID-19 patients

References

    1. Naming the coronavirus disease (COVID-19) and the virus that causes it (2020). https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technica...
    1. Coronavirus disease (COVID-2019) situation reports (2020). https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio...
    1. Novel Coronavirus – China (2020). https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/
    1. Interim Guidance: Healthcare Professionals 2019-nCoV|CDC (2020). https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-criteria.html
    1. Yang Yang MY, Shen Chenguang, Wang Fuxiang, Yuan Jing, Li Jinxiu, Zhang Mingxia, Wang Zhaoqin, Xing Li, Wei Jinli, Peng Ling, Wong Gary, Zheng Haixia, Weibo Wu, Liao Mingfeng, Feng Kai, Li Jianming, Yang Qianting, Zhao Juanjuan, Zhang Zheng, Liu Lei, Liu Yingxia. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. medRxiv. 2020;1:5. doi: 10.1101/2020.02.11.20021493. - DOI - PMC - PubMed

MeSH terms